Boston Scientific's "blockbuster" Synergy stent for opening blocked arteries on the heart commands a higher price than its competitors, but so far the jury is out on whether it can prevent long ...

And with the use of a BP-DES, such as Boston Scientific's Synergy, the polymer is fully absorbed shortly after drug-elution is complete, to hasten healing of the tissue around the stent.

Natick, MA - The Synergy everolimus-eluting coronary stent (Boston Scientific), with a bioabsorbable polymer coating that eventually disappears after releasing the drug, has received the CE Mark ...

CHICAGO, Nov 19 (Reuters) - Boston Scientific Corp's next generation Synergy heart stent succeeded in a pivotal study that will be used to seek U.S. and Japanese approval of the device ...

The primary clinical and angiographic endpoints of this non-inferiority study, which compares the SYNERGY Stent to the PROMUS Element Stent, have already been published. "The clinical results of the ...

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions Receive the the latest news, research, and ...

NATICK, Massachusetts — The Synergy everolimus-eluting coronary stent (Boston Scientific), with a bioabsorbable polymer coating that eventually disappears after releasing the drug, has received ...